Elevated Prolactin Levels Are Associated With Increased Severity and Psychiatric Symptoms in Anti‐N‐Methyl‐D‐Aspartate Receptor Encephalitis
Brain and Behavior · 2025-11 · 15 (11)
DOI: 10.1002/brb3.70960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 29.10.2025. Verfasst von Xiaoyu Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Qilu Hospital of Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Prolactin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
Autoimmune encephalitis, predominantly anti‐N‐methyl‐D‐aspartate receptor (anti‐NMDAR) encephalitis, is a central nervous system (CNS) autoimmune disorder. Prolactin (PRL), a pro‐inflammatory hormone implicated in autoimmune pathogenesis, may play a role in anti‐NMDAR encephalitis, though its clinical relevance remains unclear.
Methods
Serum PRL levels were compared between anti‐NMDAR encephalitis patients and healthy controls (HCs). Correlations between PRL levels and disease severity were analyzed. Subgroup analyses were performed based on clinical manifestations, tumor comorbidity, ICU admission, disease severity, and MRI abnormalities. Longitudinal PRL levels and modified Rankin Scale (mRS) scores were evaluated in 28 patients during follow‐up. In addition, associations between PRL and inflammatory markers, including neutrophil‐to‐lymphocyte ratio (NLR), were investigated.
Results
Anti‐NMDAR encephalitis patients exhibited significantly elevated PRL levels compared to HCs ( p < 0.001), with PRL positively correlated with baseline disease severity. After a 3‐month treatment period, both PRL levels and mRS scores decreased significantly ( p = 0.002, p < 0.001, respectively), and their reductions showed a positive correlation ( r = 0.407, p = 0.032). PRL levels were associated with psychiatric symptoms but not with seizures, prodromal fever, speech deficits, or sleep disturbances. Furthermore, PRL abundance correlated with systemic inflammatory markers, notably NLR.
Conclusions
Circulating PRL levels are significantly elevated in anti‐NMDAR encephalitis and correlate with disease activity, suggesting its potential utility as a biomarker for monitoring disease progression. The pathophysiological role of PRL—whether pathogenic or protective—warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Second Qilu Hospital of Shandong University, Jinan, China.
- Department of Clinical Data Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Department of Neurology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
- Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Ma, X., Lu, Y., Xu, Y., Guo, S., Wang, W., Shang, W., Qiu, W., Wang, P., Shu, Y., & Wang, Y. (2025). Elevated Prolactin Levels Are Associated With Increased Severity and Psychiatric Symptoms in Anti‐N‐Methyl‐D‐Aspartate Receptor Encephalitis. Brain and Behavior, 15(11). https://doi.org/10.1002/brb3.70960
Vancouver
Ma X, Lu Y, Xu Y, Guo S, Wang W, Shang W, et al. Elevated Prolactin Levels Are Associated With Increased Severity and Psychiatric Symptoms in Anti‐N‐Methyl‐D‐Aspartate Receptor Encephalitis. Brain and Behavior. 2025;15(11). doi:10.1002/brb3.70960
BibTeX
@article{Ma2025,
author = {Ma, Xiaoyu and Lu, Yaxin and Xu, Yingying and Guo, Shougang and Wang, Weiqi and Shang, Wei and Qiu, Wei and Wang, Pin and Shu, Yaqing and Wang, Yuge},
title = {Elevated Prolactin Levels Are Associated With Increased Severity and Psychiatric Symptoms in Anti‐N‐Methyl‐D‐Aspartate Receptor Encephalitis},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {11},
doi = {10.1002/brb3.70960}
}
EUVIMED